Turnstone Biologics Corp. Files 8-K/A Amendment
| Field | Detail |
|---|---|
| Company | Turnstone Biologics Corp. |
| Form Type | 8-K/A |
| Filed Date | Jul 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
Turnstone Biologics filed an amendment to its 8-K, adding financial statements and exhibits.
AI Summary
Turnstone Biologics Corp. filed an amendment (8-K/A) on July 1, 2025, to its report originally filed on June 26, 2025. This amendment specifically pertains to the filing of financial statements and exhibits. The company, incorporated in Delaware, is involved in biological products and is headquartered in La Jolla, California.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to the initial disclosure, which could be important for investors to review for updated information.
Risk Assessment
Risk Level: low — This is a procedural amendment to a previous filing, not a disclosure of new material events.
Key Players & Entities
- Turnstone Biologics Corp. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- La Jolla, California (location) — Business and mail address
- June 26, 2025 (date) — Date of earliest event reported
- July 1, 2025 (date) — Date of report (filing date)
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing serves as an amendment to a previously filed 8-K report, specifically to include financial statements and exhibits.
When was the original report filed?
The original report was filed on June 26, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at 9310 Athena Circle, Suite 3000, La Jolla, California 92037.
What is Turnstone Biologics Corp.'s industry?
Turnstone Biologics Corp. is in the Biological Products (No Diagnostic Substances) industry, SIC code 2836.
What is the filing date of this amendment?
This amendment (8-K/A) was filed on July 1, 2025.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on July 1, 2025 regarding Turnstone Biologics Corp..